Fructose, but not dextrose, accelerates the progression of chronic kidney disease

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 4, 2007, Pages

  Gersch, Michael S ^a,b,c   Mu, Wei ^a   Cirillo, Pietro ^a   Reungjui, Sirirat ^a   Zhang, Li ^a   Roncal, Carlos ^a   Sautin, Yuri Y ^a   Johnson, Richard J ^a   Nakagawa, Takahiko ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

High fructose corn syrup; Metabolic syndrome; Monocyte chemoattractant protein 1

Indexed keywords

FRUCTOSE; GLUCOSE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIET; DISEASE COURSE; FIBROBLAST; GLOMERULOSCLEROSIS; KIDNEY PARENCHYMA; MALE; METABOLIC SYNDROME X; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SPRAGUE DAWLEY RAT;

EID: 35148862908     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00181.2007     Document Type: Article

References (38)

1. Bantle JP. Is fructose the optimal low glycemic index sweetener? Nestle Nutr Workshop Ser Clin Perform Programme 11: 83-95, 2006.
2. Bar-On H, Stein Y. Effect of glucose and fructose administration on lipid metabolism in the rat. J Nutr 94: 95-105, 1968.
3. Boot-Handford RP, Heath H. The effect of dietary fructose and diabetes on the rat kidney. Br J Exp Pathol 62: 398-406, 1981.
4. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79: 537-543, 2004.
5. Buemann B, Toubro S, Holst JJ, Rehfeld JF, Bibby BM, Astrup A. d-Tagatose, a stereoisomer of d-fructose, increases blood uric acid concentration. Metabolism 49: 969-976, 2000.
6. Bukar J, Mezitis NH, Saitas V, Pi-Sunyer FX. Frozen desserts and glycemic response in well-controlled NIDDM patients. Diabetes Care 13: 382-385, 1990.
7. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140: 167-174, 2004.
8. Cohen AM, Teitelbaum A. Effect of glucose, fructose, sucrose and starch on lipogenesis in rats. Life Sci 7: 23-29, 1968.
9. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003.
10. Dominguez JH, Wu P, Hawes JW, Deeg M, Walsh J, Packer SC, Nagase M, Temm C, Goss E, Peterson R. Renal injury: similarities and differences in male and female rats with the metabolic syndrome. Kidney Int 69: 1969-1976, 2006.
11. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76: 911-922, 2002.
12. Guthrie JF, Morton JF. Food sources of added sweeteners in the diets of Americans. J Am Diet Assoc 100: 43-51, 2000.
13. Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 15: 1677-1689, 2004.
14. Huang YJ, Fang VS, Juan CC, Chou YC, Kwok CF, Ho LT. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation. Metabolism 46: 1252-1258, 1997.
15. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 10: 512-516, 1987.
16. Hwang IS, Huang WC, Wu JN, Shian LR, Reaven GM. Effect of fructose-induced hypertension on the renin-angiotensin-aldosterone system and atrial natriuretic factor. Am J Hypertens 2: 424-427, 1989.
17. Jacobson MF. High-fructose corn syrup and the obesity epidemic. Am J Clin Nutr 80: 1081-1082, 2004.
18. Jurgens H, Haass W, Castaneda TR, Schurmann A, Koebnick C, Dombrowski F, Otto B, Nawrocki AR, Scherer PE, Spranger J, Ristow M, Joost HG, Havel PJ, Tschop MH. Consuming fructose-sweetened beverages increases body adiposity in mice. Obes Res 13: 1146-1156, 2005.
19. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13: 2888-2897, 2002.
20. Kasiske BL, O'Donnell MP, Garvis WJ, Keane WF. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res 62: 367-374, 1988.
21. Kaufmann NA, Poznanski R, Blondheim SH, Stein Y. Comparison of effects of fructose, sucrose, glucose, and starch on serum lipids in patients with hypertriglyceridemia and normal subjects. Am J Clin Nutr 20: 131-132, 1967.
22. Kaufmann NA, Poznanski R, Blondheim SH, Stein Y. Effect of fructose, glucose, sucrose and starch on serum lipids in carbohydrate induced hypertriglyceridemia and in normal subjects. Isr J Med Sci 2: 715-726, 1966.
23. Klahr S. The modification of diet in renal disease study. N Engl J Med 320: 864-866, 1989.
24. Krilanovich NJ. Fructose misuse, the obesity epidemic, the special problems of the child, and a call to action. Am J Clin Nutr 80: 1446-1448, 2004.
25. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140, 2005.
26. Mantych GJ, James DE, Devaskar SU. Jejunal/kidney glucose transporter isoform (Glut-5) is expressed in the human blood-brain barrier. Endocrinology 132: 35-40, 1993.
27. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290: F625-F631, 2006.
28. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 1: 80-86, 2005.
29. Nikkila EA, Ojala K. Acute effects of fructose and glucose on the concentration and removal rate of plasma triglyceride. Life Sci 5: 89-94, 1966.
30. Sanchez-Lozada LG, Tapia E, Jimenez A, Bautista P, Cristobal M, Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ, Herrera-Acosta J, Franco M. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 292: F423-F429, 2007.
31. Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 26: 232-244, 2006.
32. Uusitupa MI. Fructose in the diabetic diet. Am J Clin Nutr 59: 753S-757S, 1994.
33. Vasdev S, Longerich L, Gill V. Prevention of fructose-induced hypertension by dietary vitamins. Clin Biochem 37: 1-9, 2004.
34. Wang YM, van Eys J. Nutritional significance of fructose and sugar alcohols. Annu Rev Nutr 1: 437-475, 1981.
35. Yoshida K, Kohzuki M, Xu HL, Wu XM, Kamimoto M, Sato T. Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure. J Hypertens 19: 503-510, 2001.
36. Yu XQ, Fan JM, Nikolic-Paterson DJ, Yang N, Mu W, Pichler R, Johnson RJ, Atkins RC, Lan HY. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. Am J Pathol 154: 833-841, 1999.
37. Zakim D, Pardini R, Herman RH, Sauberlich H. The relation of hepatic α-glycerophosphate concentration to lipogenesis in rat liver. Biochim Biophys Acta 137: 179-180, 1967.
38. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-de la Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal anti-transforming growth factor-β antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97: 8015-8020, 2000.